Navigation Links
Telik Announces Patents on Compounds Related to TELINTRA
Date:6/10/2008

PALO ALTO, Calif., June 10 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK), announced today that the European Patent Office has issued notices of allowance for two applications covering new compounds related to one of Telik's lead clinical candidates, TELINTRA(R). Corresponding applications have already issued as patents in the United States; and other applications are pending in major countries worldwide.

TELINTRA is currently in Phase 2 clinical trials for the treatment of Myelodysplastic Syndrome, a form of pre-leukemia, and for Chemotherapy Induced Neutropenia, a common side effect of chemotherapy. Telik expects these applications and patents to provide broad intellectual property protection to compounds related to TELINTRA, according to Derek Freyberg, Ph.D., Telik's VP, Intellectual Property. The patents will help to broaden and strengthen Telik's intellectual property estate and may support additional clinical development candidates.

About Telik

Telik, Inc. of Palo Alto, California, is a biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. The company's most advanced investigational drug candidates in clinical development are TELINTRA, a modified glutathione analog for the treatment of cytopenias due to myelodysplastic syndrome or chemotherapy, and TELCYTA(R), a tumor-activated prodrug for the treatment of advanced ovarian cancer and non-small cell lung cancer. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates.

This press release contains "forward-looking" statements, including statements
'/>"/>

SOURCE Telik, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Telik Announces Preclinical Presentations at AACR Annual Meeting
2. Telik Reports Positive Results From Phase 1 Dose-Escalation Study of TELINTRA Tablets in Myelodysplastic Syndrome
3. Selective Insurance Group Announces Officer Appointments
4. Nonin(R) Medical Announces Strategic Relationship With Microsoft and its Microsoft HealthVault Platform
5. Shared Health(R) Announces New Data Exchange Platform
6. China Sky One Medical, Inc. Announces Guidance for Second Quarter and Full Year 2008
7. Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes
8. NBTY Announces Agreement to Purchase Leiner Health Products
9. CorVel Announces Record Earnings
10. SUA Insurance Company Announces Partnership With American Safety Indemnity Company
11. WellPoint Announces Appearance at Upcoming Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009).... 27 Shamir Optical Indu... provider of innovative products and technology to...its board of directors had declared a dividend dis... (approximately NIS 37.62 million based on the Nov...r approximately US$ 0.609 (approximately NIS 2.3 b...
(Date:11/27/2009)...vehicles may reduce future disease burden, researc...News) -- Encouraging city dwellers to walk and bic...r public health benefits than increased used of lo..., The study compared the projected health effec...narios for London, England, and Delhi, India: bus...
(Date:11/27/2009)...ov. 27 Allrecipes.com , the wor...ng traffic numbers, with more than 2.8 million vis...ar picture of what was served on the biggest food ... in 2009 weighed in at 2,225 calories per serving,...rding to the Allrecipes site, Sweet Potato Pie I ...
(Date:11/27/2009)...e bilingual coloring books designed for children a...unity to educate - inform parents and children ali...Dinosuars to ABC,S and a host of other topics. , ...vember 27, 2009 -- Today’s children have eno... any hour of the day, but one of the oldest and si...
(Date:11/27/2009)...teractive anatomy education apps from Modality and...ciences learning opportunities for iPhone and iPod...s) November 27, 2009 -- Modality, Inc. and Lippi...Wolters Kluwer Health, today announced the availab...pp Store. Clemente’s Anatomy, Rohen’s ...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5
...at the U.S. Department of Energy,s Brookhaven Nati...in level of receptors for dopamine, a pleasure-rel...cent in rats trained to self-administer it. Earlie...ve useful in treating addiction, according to the ...
...16 The Blackstone,Group has today informed us tha... Gerresheimer AG, held by BCP Murano II S.a.r.l. w...tion, led by Credit Suisse, 7.8 million,shares wil...07. Dr. Axel Herberg, CEO of Gerresheimer AG: "Bla...
...ay is National Skin Cancer,Awareness Month. TOPEX,...his disease with a low energy or superficial x-ray...ent procedure. This new system provides,an alterna...sitive structures in the head and neck regions -- ...
...omen with breast cancer have worse disease outcome... first time with more advanced disease, two scient...e (EBCC-6) today (Wednesday 16 April). , Dr. E...howed that women who had a body mass index (BMI) o...
...O2 Plastics, Inc.,(OTC Bulletin Board: ECOO), the ...e way plastics are recycled, today reported its 20.... The Company reported revenues of,$4.3 million fo... $32.6 million in 2007 versus $20.8 million for th...
...ers at the Duke School of Medicine apparently have...so much, and it may be a mechanism that could lead... a graduate student in Assistant Professor Jeffrey...ogrammed cell death. They make use of a protein ca...
Other Medicine News:Health News:Gene therapy reduces cocaine use in rats 2Health News:An Alternative to Surgery for Treating Skin Cancer 2Health News:An Alternative to Surgery for Treating Skin Cancer 3Health News:Obese women disadvantaged in both breast cancer treatment and diagnosis 2Health News:Obese women disadvantaged in both breast cancer treatment and diagnosis 3Health News:ECO2 Plastics, Inc. Reports 2007 Year End Financial Results, Announces FDA Filing and Provides Outlook for 2008 2Health News:ECO2 Plastics, Inc. Reports 2007 Year End Financial Results, Announces FDA Filing and Provides Outlook for 2008 3Health News:A potential sugar fix for tumors 2
(Date:11/25/2009)..., NEW YORK, Nov. 25 Reportlinker...s available in its catalogue: ,, Intranasal Dr...tp://www.reportlinker.com/p0164267/Intranasal-Drug... The US intranasal drug delivery market is witness...the delivery of conventional local therapeutic dru...
(Date:11/25/2009)...NTAIN VIEW, Calif., Nov. 25 Chem...clinical data from the Company,s PROTECT-1 (the Pr...ohn,s disease Trial) of Traficet-EN(TM) (CCX282-B)...se demonstrated clinical efficacy with a favorable...strated evidence of clinical efficacy in the reduc...
(Date:11/24/2009)...VINE, Calif., Nov. 24 En...ally invasive treatments for aortic disorders, ann...r discontinue all proceedings in, the patent infri... by Cook, Inc. The motion was filed in the United..., Endologix has requested that the stay remain ...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 1YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 3BeamOne LLC to Add New Ebeam Sterilization Service Center 6384 1BeamOne LLC to Add New Ebeam Sterilization Service Center 6384 2Residential design for persons with neurological disability 61642 1Residential design for persons with neurological disability 61642 2Residential design for persons with neurological disability 61642 3
...etween drug-eluting stent brands , , NATICK, Mass...BSX ) today welcomed the publication of an article... College of Cardiology (JACC) reviewing data on mo...registry who were evaluated for restenosis, or the...ary intervention (PCI). The article reported that...
...May 8 New recommendations released today by a con...al Endocrinologists (AACE) and the American Diabet... in the way health care professionals treat hospit...vels. The authors recommend revised glucose targe...n 100-180 mg/dL for most patients admitted to gene...
Other Medicine Technology:Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent 2Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent 3Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent 4Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent 5Diabetes Experts Issue New Recommendations for Inpatient Glycemic Control - Call for Systemic Changes in Hospitals Nationwide 2Diabetes Experts Issue New Recommendations for Inpatient Glycemic Control - Call for Systemic Changes in Hospitals Nationwide 3
Lasik Irrigator - 4 ports
Lasik Cannula - Rosen
Anterior Chamber Maintainer
Sub-Tenon's Cannula
Medicine Products: